ArticlePloS one2023
A3SOM, abstained explainable semi-supervised neural network based on self-organizing map.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comparison and benchmark of deep learning methods for non-coding RNA classification.PLoS computational biology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the sea of data generated daily, unlabeled samples greatly outnumber labeled ones. This is due to the fact that, in many application areas, labels are scarce or hard to obtain. In addition, unlabeled samples might belong to new classes that are not available in the label set associated with data. In this context, we propose A3SOM, an abstained explainable semi-supervised neural network that associates a self-organizing map to dense layers in order to classify samples. Abstained classification enables the detection of new classes and class overlaps. The use of a self-organizing map in A3SOM allows integrated visualization and makes the model explainable. Along with describing our approach, this paper shows that the method is competitive with other classifiers and demonstrates the benefits of including abstention rules. A use case is presented on breast cancer subtype classification and discovery to show the relevance of our method in real-world medical problems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.